Founded in 1980 in Taipei, Taiwan, TCI Co., Ltd (“TCI”) has transformed over the past 42 years into a global powerhouse in biotechnology and life sciences. As a Contract Development and Manufacturing Organization (“CDMO”), TCI integrates disciplines such as chemistry, biology, mathematics, industrial engineering, genetic medicine, aesthetics, ergonomics, and consumer behavior research to design high-performance bioscience solutions.
Operating in 63 countries, TCI provides health foods, skincare, medical devices, and pharmaceuticals. Its collaboration with subsidiaries like TCI Gene, TCI Living, IOPACKAGE, MBI, and PetFood Biotechnology strengthens its strategic alliances in biotechnology and life sciences. This collective approach aligns with TCI Group’s vision of becoming a biotechnology-focused, diversified bioscience design trading company.
Innovating for a Sustainable Future
TCI’s expertise as a CDMO allows it to pioneer unique product formulations and manufacturing solutions. With operational hubs in Asia, Europe, and North America, the company caters to a global clientele. In 2021, its consolidated revenue reached NTD 8.58 billion, a testament to its strategic planning and balanced approach to economic, environmental, and social development.
Recognized as one of HR Asia’s “Best Companies to Work for in Asia” and a recipient of the “Happy Enterprise” Gold Award from 1111 Job Bank, TCI has built a resilient and people-focused workplace. These accolades highlight its commitment to employee well-being, sustainable practices, and positive industry influence.
Strategic Expansion and Visionary Growth
In 2021, TCI launched its “Integrated Bioscience Design Trading Company” concept, marking a strategic shift toward global expansion. Through mergers and acquisitions, the company is creating dense customer networks that connect cities with industry value chains. This customer-centric approach underscores TCI’s commitment to integrating bioscience design into everyday life.
Challenges such as global epidemics, climate change, and supply chain disruptions have further strengthened TCI’s resolve. By focusing on sustainability, the company proactively sets short, medium, and long-term goals that balance environmental responsibility with scientific innovation.
Commitment to Quality and Ethical Standards
TCI’s dedication to excellence is evident in its state-of-the-art Rock Park factory, which holds certifications including GMP, GMPC, FSSC22000, HACCP, ISO 9001, ISO 17025, ISO 22000, ISO 22716, ISO 14001, ISO 50001, OHSAS 18001, and ISO 45001. Additionally, it has obtained SMETA, BRC Retailers Association, U.S. NSF, and TGA certifications, underscoring its commitment to ethical practices, safety, and product quality.
For over four decades, TCI has remained at the forefront of bioscience innovation and sustainability. By pioneering cutting-edge research and developing products that impact millions, the company continues to shape the future of bioscience design. Rooted in trust, creation, and intelligence, TCI is poised to make a lasting imprint on the industry, driving global progress in biotechnology and life sciences.
